This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suven Life Sciences Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Nageshwara Rao Muddana: Innovator in Pharmaceutical Compounds
Introduction
Nageshwara Rao Muddana is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that address various health disorders. His work is characterized by a commitment to innovation and a focus on improving patient outcomes.
Latest Patents
Nageshwara Rao Muddana holds a patent related to heterocyclyl compounds of formula (I) and their pharmaceutically acceptable salts and compositions. This invention is particularly relevant for the treatment of disorders associated with Histamine H receptors, including cognitive disorders, sleep disorders, obesity, and pain. The patent showcases his expertise in creating compounds that have the potential to make a meaningful impact on healthcare.
Career Highlights
Muddana is associated with Suven Life Sciences Limited, a company known for its dedication to research and development in the pharmaceutical sector. His role at the company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative drug development.
Collaborations
Some of his notable coworkers include Ramakrishna Nirogi and Anil Karbhari Shinde. Their collective efforts in research and development have fostered an environment of creativity and innovation within the company.
Conclusion
Nageshwara Rao Muddana's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile